GATXHIGH SIGNALFINANCIAL10-K

GATX executed a substantial balance sheet expansion with debt growing by over 50% to $12.5B while cash holdings roughly doubled to $743M, suggesting major fleet investments or potential acquisition activity.

The dramatic increase in both debt levels and cash position indicates GATX is in an active growth phase, likely expanding its rail car and locomotive leasing portfolio significantly. The 32.6% increase in capital expenditures to $1.7B supports this thesis of substantial fleet investments, which should drive future revenue growth but increases financial leverage and interest expense burden.

Comparing 2026-02-19 vs 2025-02-19View on EDGAR →
FINANCIAL ANALYSIS

GATX's balance sheet underwent major expansion with total assets growing 46% to $18B, driven primarily by substantial debt issuance that increased borrowings to $12.5B. The company maintained strong liquidity with cash holdings roughly doubling to $743M while generating solid profitability with net income growing 17% to $333M. The financial profile reflects an aggressive growth strategy with higher leverage but adequate cash cushion and continued earnings momentum.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+85%
$401.6M→$743.0M

Cash position surged 85% — strong cash generation or capital raise providing significant financial cushion.

Provision for Credit Losses
P&L
+65.6%
-$3.2M→-$1.1M

Credit loss provisions surged 65.6% — management flagging significant deterioration in loan quality ahead.

Total Debt
Balance Sheet
+51.2%
$8.3B→$12.5B

Debt increased 51.2% — substantial leverage increase; assess whether deployed for growth or covering losses.

Total Assets
Balance Sheet
+46.4%
$12.3B→$18.0B

Asset base grew 46.4% — expansion through organic growth, acquisitions, or capital deployment.

Total Liabilities
Balance Sheet
+45.7%
$9.9B→$14.4B

Liabilities grew 45.7% — significant increase in debt or obligations, assess impact on financial flexibility.

Capital Expenditure
Cash Flow
+32.6%
$1.3B→$1.7B

Capital expenditure jumped 32.6% — major investment cycle underway; assess returns on deployment.

Net Income
P&L
+17.3%
$284.2M→$333.3M

Net income grew 17.3% — bottom-line growth signals improving overall business health.

Stockholders Equity
Balance Sheet
+12.8%
$2.4B→$2.8B

Equity base grew 12.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-02-19
PRIOR — 2025-02-19
ADDED
There were 35.5 million common shares outstanding at January 31, 2026.
Market for Registrant s Common Equity, Related Stockholder Matters , and Issuer Purchases of Equity Securities 26 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 28 Discussion of Operating Results 29 Change in Net Operating Assets and Facilities 44 Cash Flow Discussion 44 Liquidity and Capital Resources 46 Critical Accounting Policies and Estimates 50 New Accounting Pronouncements 52 Non-GAAP Financial Measures 52 Item 7A.
We do not undertake any obligation to publicly update or revise these forward-looking statements, except to the extent required by applicable law.
The following factors, among others and in addition to the risks, uncertainties, and other important factors discussed under "Risk Factors" and elsewhere in this report and in our other filings with the U.S.
+7 more — sign up free →
REMOVED
There were 35.6 million common shares outstanding at January 31, 2025.
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 25 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 27 Discussion of Operating Results 28 Change in Net Operating Assets and Facilities 43 Cash Flow Discussion 43 Liquidity and Capital Resources 45 Critical Accounting Policies and Estimates 49 New Accounting Pronouncements 51 Non-GAAP Financial Measures 51 Item 7A.
We do not undertake any obligation to publicly update or revise these forward-looking statements.
The following factors, in addition to those discussed under "Risk Factors" and elsewhere in this report and in our other filings with the U.S.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →